Peptide South AfricaPeptide South Africa

    Pharmacokinetics

    Retatrutide's 144-Hour Half-Life: Why You Shouldn't Judge Your Dose After One Shot

    Everyone focuses on the dose — 1 mg, 2 mg, 4 mg. But how long retatrutide stays in your system may matter just as much. Here's the half-life, explained.

    Updated 12 August 20266 min readBy Peptide South Africa Editorial

    A lot of people judge retatrutide by one number: the dose on the syringe. 1 mg. 2 mg. 4 mg. But personally, I think understanding how long Reta stays in your system is just as important as the number you inject.

    The number most people miss: ~6 days

    Retatrutide has a half-life of roughly six days — about 144 hours. In plain terms: a dose you take today doesn't just disappear before your next injection. Roughly six days later, about half of that exposure may still be there, and it keeps tapering down from there.

    That single fact is what made weekly dosing finally make sense to me. You're not starting from zero every week.

    Why weekly dosing builds up

    Inject once a week and the next dose lands while some of the previous one is still around. Then the next week, the same thing happens again. So over the first few weeks, the drug is gradually building toward a more stable level in your body rather than spiking and vanishing each time.

    Why week 1 and week 5 feel so different

    This is also why you shouldn't be too quick to judge a dose after a single injection. Week one you think, “I barely feel anything.” Week two you're already thinking about increasing. Then week three. Then suddenly around week four or five everything feels much stronger — because you've been adding new doses while some of the previous ones were still present.

    That doesn't mean you won't feel anything early — you absolutely can. It just means your body may still be building consistent exposure during those first weeks.

    Patience is part of the protocol

    With something like Reta, patience is part of the protocol. Sometimes a dose isn't doing “nothing” — you just haven't given it enough time to fully show you what it's doing yet. Understanding the 144-hour half-life completely changed how I look at weekly dosing: Reta isn't a drug you judge day by day. You have to look at it over weeks.

    References

    1. Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023.
    2. Hallare J, Gerriets V. Half Life. StatPearls (NCBI Bookshelf) — steady state is reached in ~4–5 half-lives.

    Frequently asked questions

    Join the community

    Cape Town Peptide Club

    Workshops, GP-led Q&A and a vetted peer network for longevity-focused biohackers in SA.

    Visit the Club

    Disclaimer: Content is for educational and research purposes only and does not constitute medical advice. Peptides discussed are not registered medicines in South Africa for the indications mentioned; consult a registered medical practitioner before starting any protocol.